SignalFDA/Bio

Amgen (AMGN) Posted Positive Phase 3 Results In Sjögren's Disease

Positive Phase 3 results in Sjögren's disease signal a potential new indication for Amgen.

What changed

Positive Phase 3 results in Sjögren's disease signal a potential new indication for Amgen.

Why it matters

Positive Phase 3 results in Sjögren's disease signal a potential new indication for Amgen. — impact context not separately stored; see What changed.

Sources